{"url_path":"/sec/inbp/8-k/2026-02-18/item-9-01","section_key":"item-9-01","section_title":"Item 9.01 Financial Statements and Exhibits.**","topic":"sec","document":{"doc_type":"8-K","doc_date":"2026-02-18","source_url":"https://www.sec.gov/Archives/edgar/data/1016504/0001437749-26-004553-index.html","accession_number":"0001437749-26-004553","cik":"0001016504","ticker":"INBP","issuer_name":"INTEGRATED BIOPHARMA INC","edgar_url":"https://www.sec.gov/Archives/edgar/data/1016504/0001437749-26-004553-index.html","primary_entity_key":"0001016504","primary_entity_name":"INTEGRATED BIOPHARMA INC"},"word_count":126,"has_tables":true,"body_markdown":"**Item 9.01 Financial Statements and Exhibits.**\n\n** **\n\n(d) Exhibits.\n\n \n\n \n\n10.1\n\n \n\n[Fourth Amendment of Lease, dated February 17, 2026, between Vitamin Realty Associates, L.L.C. and Manhattan Drug Company, Inc.](ex_922144.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n-1-\n\n \n\n \n\n \n\n \n\n**EXHIBIT INDEX**\n\n \n\n \n \n \n\n**Exhibit**\n\n  \n\n**Description**\n\n \n \n\n10.1\n\n  \n\n[Fourth Amendment of Lease, dated February 17, 2026, between Vitamin Realty Associates, L.L.C. and Manhattan Drug Company, Inc.](ex_922144.htm)\n\n104\n \nCover Page Interactive Data File (embedded within the Inline XBRL document)\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n-2-\n\n \n\n \n\n \n\n \n\n \n\n**SIGNATURE**\n\n \n\nPursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.\n\n \n\n \n\n  **INTEGRATED BIOPHARMA, INC.**\n\n \n \n\nDate: February 18, 2026\n\nBy:     */s/ Dina L Masi*\n\n \n\n           Dina L. Masi\n\n \n\n           Chief Financial Officer\n\n** **\n\n**                                   **\n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n \n\n###  \n\n-3-"}